论文部分内容阅读
目的探讨和分析缬沙坦联合美托洛尔治疗慢性心力衰竭的临床疗效。方法将我院2010年6月-2011年8月收治的65例慢性心力衰竭患者随机分为观察组32例和对照组33例,对照组给予强心药、利尿剂等常规治疗,观察组在常规治疗上给予缬沙坦和美托洛尔治疗,疗程均为3个月,观察对比两组的临床疗效。结果 65例患者经过临床治疗观察组32例患者总有效率为93.7%,对照组33例患者总有效率为72.7%,两组患者总有效率比较差异有统计学意义(P<0.05)。结论缬沙坦联合美托洛尔治疗慢性心力衰竭,疗效显著,值得临床进一步借鉴和推广应用。
Objective To investigate and analyze the clinical efficacy of valsartan combined with metoprolol in the treatment of chronic heart failure. Methods Sixty-five patients with chronic heart failure who were admitted to our hospital from June 2010 to August 2011 were randomly divided into observation group (32 cases) and control group (33 cases). The control group was given constipation and diuretic therapy. The observation group Routine treatment was given valsartan and metoprolol treatment, treatment were 3 months, compared the clinical efficacy of the two groups observed. Results The total effective rate was 93.7% in 32 patients in clinical observation group and 72.7% in control group. The total effective rate in two groups was statistically significant (P <0.05). Conclusion Valsartan combined with metoprolol in the treatment of chronic heart failure has significant curative effect and is worth further reference and popularization and application in clinic.